Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 27 (8), 402-9

Translocator Protein (18kDa): New Nomenclature for the Peripheral-Type Benzodiazepine Receptor Based on Its Structure and Molecular Function

Affiliations
Review

Translocator Protein (18kDa): New Nomenclature for the Peripheral-Type Benzodiazepine Receptor Based on Its Structure and Molecular Function

Vassilios Papadopoulos et al. Trends Pharmacol Sci.

Abstract

The peripheral-type benzodiazepine receptor or recognition site (PBR) is a widely distributed transmembrane protein that is located mainly in the outer mitochondrial membrane. The PBR binds to high-affinity drug ligands and cholesterol. Many functions are associated directly or indirectly with the PBR, including the regulation of cholesterol transport and the synthesis of steroid hormones, porphyrin transport and heme synthesis, apoptosis, cell proliferation, anion transport, regulation of mitochondrial functions and immunomodulation. Based on these functions, there are many potential clinical applications of PBR modulation, such as in oncologic, endocrine, neuropsychiatric and neurodegenerative diseases. Although "PBR" is a widely used and accepted name in the scientific community, recent data regarding the structure and molecular function of this protein increasingly support renaming it to represent more accurately its subcellular role (or roles) and putative tissue-specific function (or functions). Translocator protein (18kDa) is proposed as a new name, regardless of the subcellular localization of the protein.

Similar articles

See all similar articles

Cited by 389 articles

See all "Cited by" articles

Publication types

LinkOut - more resources

Feedback